What Is an ERCP? Why It's Done, What to Expect, and the Known Risks
ERCP combines endoscopy and X-rays to treat bile and pancreatic duct problems. Learn why it is done, what to expect, the known risks, and warning signs.
Olympus duodenoscopes have been linked to serious bacterial infections following ERCP, colonoscopy, and bronchoscopy procedures. Lawsuits allege the devices were defectively designed and impossible to fully sterilize between patients — and that Olympus knew it.
A duodenoscope is a long, flexible lighted tube threaded through the mouth, stomach, and into the duodenum. Physicians use it to perform ERCP (endoscopic retrograde cholangiopancreatography) — a procedure that diagnoses and treats problems with the bile ducts, pancreas, and gallbladder. The FDA has put U.S. demand at roughly 500,000 ERCP procedures a year, and news reports have cited figures as high as 700,000. Olympus has been the market leader; a 2017 report put its U.S. share at 85 percent.
Unlike disposable instruments, duodenoscopes are reusable: hospitals clean and reprocess them between patients according to the manufacturer's instructions. The litigation centers on whether that's actually possible with Olympus's design.
Devices named in current claims
At the tip of an Olympus duodenoscope sits an "elevator" mechanism — a moving part that angles surgical tools during the procedure. Lawsuits allege its narrow channels and crevices trap organic material and bacteria even when hospitals follow Olympus's own reprocessing instructions exactly.
Outbreaks of drug-resistant "superbug" infections — including CRE (carbapenem-resistant Enterobacteriaceae) — were traced to contaminated duodenoscopes at hospitals including Virginia Mason Medical Center in Seattle and Ronald Reagan UCLA Medical Center. The FDA has said as many as 350 patients at 41 medical centers worldwide were infected or exposed to contaminated duodenoscopes from the three manufacturers between 2010 and 2015. A 2016 Senate health committee minority staff report tied 19 of 25 outbreaks to Olympus scopes.
In 2017, a Seattle jury ordered Olympus to pay Virginia Mason Medical Center $6.6 million for failing to provide adequate warnings about its scope. The jury rejected the claim that the scope's design was unsafe and found the hospital partly responsible, ordering it to pay the patient's family $1 million. In 2018, Olympus Medical Systems and a former executive pleaded guilty to failing to file FDA-required adverse event reports about infections linked to its TJF-Q180V duodenoscope in Europe, and Olympus paid $85 million in fines and forfeiture.
New infection reports and an urgent Olympus safety notice for its current-generation duodenoscopes have been followed by a fresh round of lawsuits, including a wrongful death suit alleging a fatal VRE infection after an ERCP. Separately, the FDA has taken manufacturing-quality actions against Olympus, including import alerts and a warning letter, that concern other devices and do not address the infection claims.
Claims generally argue the device was defectively designed and impossible to reliably sterilize, that Olympus failed to warn hospitals and patients of the known infection risk, and that the company knew about contamination reports for years before acting.
A condensed history of the outbreaks, regulatory actions, and legal developments driving the current wave of claims.
Timeline last reviewed November 9, 2026.
Hospitals nationwide report CRE outbreaks tied to contaminated duodenoscopes used in ERCP; the FDA issues safety communications.
In the first U.S. trial over scope-linked outbreaks, a jury ordered Olympus to pay Virginia Mason Medical Center $6.6 million for inadequate warnings and instructions. It rejected the claim that the scope's design was unsafe and ordered the hospital to pay the patient's family $1 million. Read the explainer.
Olympus Medical Systems and a former executive plead guilty to failing to file FDA-required adverse event reports about infections linked to the TJF-Q180V duodenoscope in Europe. Olympus pays $85 million in fines and forfeiture.
The FDA bars new shipments into the U.S. of 58 Olympus models made in Japan, including bronchoscopes, ureterorenoscopes, laparoscopes and automated endoscope reprocessors, over unresolved quality-system violations. No duodenoscopes are on the list.
Olympus issues an Urgent Field Safety Notice for its TJF-Q190V, Q290V and Q170V duodenoscopes: updated reprocessing instructions, a new 10x-magnification inspection step, and a report of two deaths and five serious injuries since 2024 associated with infections or positive cultures.
Olympus recalls its OER-Pro automated scope reprocessor, a Class II recall the FDA posted March 20, because two valves (the MAJ-1443 and MAJ-1444) are no longer reprocessing-compatible with the OER-Pro and OER-Elite machines.
A federal wrongful death lawsuit alleges a contaminated Olympus duodenoscope transmitted a fatal VRE bloodstream infection following an ERCP.
An FDA warning letter dated October 7 cites quality-system violations at six Olympus manufacturing facilities, covering devices such as bronchoscopes, sphincterotomes and cystoscopes. The letter concerns manufacturing controls and does not address the duodenoscope infection claims. Olympus says it will respond to the FDA. Read the explainer.
The FDA adds five more Olympus models, including small-intestine and capsule endoscopy systems and bronchoscopes, bringing the import alert to 63 models and citing unresolved quality-system violations. Providers may keep using devices already in service if they are working properly. Duodenoscopes are not on the list. Read the explainer.
No multidistrict litigation has been consolidated. Cases are proceeding as individual product liability lawsuits in state and federal courts, with new claims being filed and evaluated every week.
Every case is different, and only a licensed attorney can confirm whether you have a claim. In general, you may be eligible for a free case review if any of the following apply.
Not currently. As of early November 2026, no multidistrict litigation (MDL) has been consolidated for these claims. Cases are being filed and litigated individually in state and federal courts across the country. That could change if case volume grows, but it does not affect your ability to file an individual claim now.
Depending on the facts of your case, damages in product liability claims like this can include medical expenses, lost income, pain and suffering, and — in wrongful death cases — funeral costs and loss of companionship. An attorney can only estimate potential value after reviewing your medical records and case details.
Every state sets its own statute of limitations for product liability and wrongful death claims, and the clock generally does not pause while you wait to see whether an MDL forms. If you believe you or a loved one was affected, it's worth getting a free review sooner rather than later.
No. Case reviews are free and confidential, and these claims are handled on a contingency basis — meaning there's no attorney fee unless your case results in a settlement or verdict.
Family members and estate representatives may be able to bring a wrongful death claim. Please reach out — our intake team is experienced in handling these conversations with care.
Plain-language explainers on the devices, the infections, and the legal process.
ERCP combines endoscopy and X-rays to treat bile and pancreatic duct problems. Learn why it is done, what to expect, the known risks, and warning signs.
Where the Olympus scope infection litigation stands in November 2026: the courts, the FDA's import alert and warning letter, and what to watch next.
Plain answers to common questions about Olympus scope infection lawsuits: which devices are involved, what is alleged, what the FDA has done, and time limits.
A member of our intake team will follow up within one business day. There's no cost, no obligation, and nothing you share here creates an attorney-client relationship until we agree to represent you in writing.
Prefer to talk now?
Call 1-800-LAW-FIRMA member of our intake team will call you within one business day. If it's urgent, call 1-800-LAW-FIRM directly.